Firma Clinical Research
June 24, 2020 – Firma Clinical Research, a niche service provider to the pharmaceutical and medical device industry, recently named Melissa Nezos as Vice President of Clinical Operations.
In her new role with Firma, Nezos leads project management and clinical operations for the in-home service line. She will develop and implement a strategic plan for clinical operations that supports Firma’s patient-centric vision.
For more than 20 years, Nezos worked in clinical operations and project management for global organizations., including large and mid-sized CROs. In recent years, Nezos brought her extensive clinical knowledge and expertise into the risk-based quality management and risk-based monitoring solutions environment. As an advocate for data- driven and technology-led solutions, she has leveraged her ability to work across operational functions to successfully implement innovative clinical monitoring and data quality strategies.
Prior to joining Firma, Nezos was Global Head of Clinical Operations for Premier Research. She previously served as Executive Director of Clinical Operations-America for Chiltern and Director of Clinical Operations/Director of eClinical Solutions for PRA International.
“Melissa is recognized in the industry as a champion for progress, and she has been instrumental in delivering global organizational change initiatives,” says Michael Woods, CEO, Firma Clinical Research. “The Firma team is looking forward to the positive change that Melissa will bring to Firma through technology and process solutions that are based on industry standards and benchmarks.”
Nezos holds a master’s degree in psychology and a bachelor’s degree in psychology from San Diego State University.
About Firma Clinical Research
Firma Clinical Research is a quality certified CRO built on decades of clinical development leadership and expertise. Firma supports the drug development efforts of pharmaceutical and biotech companies through in-home patient visits and data management and biostatistics. Firma’s patient-centric and collaborative approach enables clients to make informed decisions that accelerate the development of safe and effective treatments. The company offers a wide array of tailored processes and services across all phases of clinical development, strategically focusing on flexible solutions, transparent communication and on-time deliverables. For more information, visit the company at www.firmaclinicalresearch.com or follow Firma Clinical Research on Twitter or LinkedIn.